8095 Stock Overview
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Astena Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥479.00 |
| 52 Week High | JP¥548.00 |
| 52 Week Low | JP¥424.00 |
| Beta | 0.13 |
| 1 Month Change | -0.42% |
| 3 Month Change | 0% |
| 1 Year Change | 9.86% |
| 3 Year Change | -38.11% |
| 5 Year Change | 4.81% |
| Change since IPO | -5.89% |
Recent News & Updates
Shareholder Returns
| 8095 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -0.2% | -1.9% | -2.6% |
| 1Y | 9.9% | 3.2% | 28.4% |
Return vs Industry: 8095 exceeded the JP Pharmaceuticals industry which returned 3.2% over the past year.
Return vs Market: 8095 underperformed the JP Market which returned 28.4% over the past year.
Price Volatility
| 8095 volatility | |
|---|---|
| 8095 Average Weekly Movement | 2.0% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 8095 has not had significant price volatility in the past 3 months.
Volatility Over Time: 8095's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 1,404 | Satoshi Setoguchi | www.astena-hd.com |
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company’s Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division manufactures and sells semi-solid products, such as ointments, creams, and lotions, as well as solid products such as tablets and powders for the generic drug market; and manufactures a range of dosage forms, including injectable, solid, semi-solid, and liquid dosage forms on contract.
Astena Holdings Co., Ltd. Fundamentals Summary
| 8095 fundamental statistics | |
|---|---|
| Market cap | JP¥19.28b |
| Earnings (TTM) | JP¥1.62b |
| Revenue (TTM) | JP¥52.63b |
11.7x
P/E Ratio0.4x
P/S RatioIs 8095 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8095 income statement (TTM) | |
|---|---|
| Revenue | JP¥52.63b |
| Cost of Revenue | JP¥35.64b |
| Gross Profit | JP¥16.98b |
| Other Expenses | JP¥15.37b |
| Earnings | JP¥1.62b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 40.84 |
| Gross Margin | 32.27% |
| Net Profit Margin | 3.07% |
| Debt/Equity Ratio | 54.3% |
How did 8095 perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield44%
Payout RatioDoes 8095 pay a reliable dividends?
See 8095 dividend history and benchmarks| Astena Holdings dividend dates | |
|---|---|
| Ex Dividend Date | May 30 2024 |
| Dividend Pay Date | Aug 13 2024 |
| Days until Ex dividend | 40 days |
| Days until Dividend pay date | 115 days |
Does 8095 pay a reliable dividends?
See 8095 dividend history and benchmarks